Jens Ulrik Stæhr Jensen

Medicine & Life Sciences

1. Acute Kidney Injury 98%
2. Adrenal Cortex Hormones 55%
3. Anti-Bacterial Agents 37%
4. Antimicrobial Stewardship 18%
5. Biomarkers 42%
6. Candida 35%
7. Cefuroxime 55%
8. Chronic Obstructive Pulmonary Disease 61%
9. Ciprofloxacin 52%
10. Critical Care 65%
11. Critical Illness 100%
12. Disease Progression 34%
13. Eosinophils 66%
14. Equivalence Trials 46%
15. Ideal Body Weight 17%
16. Infections 16%
17. Intensive Care Units 64%
18. Kidney 28%
19. Lung 18%
20. Lung Diseases 30%
21. Mechanical Ventilators 36%
22. Meropenem 47%
23. Patient Care 26%
24. Pharmaceutical Preparations 15%
25. Platelet Count 18%
26. Prednisolone 20%
27. Procalcitonin 76%
28. Pulmonary Surfactant-Associated Protein D 44%
29. Randomized Controlled Trials 46%
30. Respiratory Insufficiency 32%
31. Respiratory Tract Infections 32%
32. Steroids 25%
33. Survival 17%
34. Tazobactam Drug Combination Piperacillin 60%
35. Therapeutics 25%
36. Thrombocytopenia 32%
37. Thrombomodulin 19%
38. Water-Electrolyte Balance 46%